A human trial for coronavirus is set to take place today in the US, according to officials.
A trial, which is being funded by the National Institutes of Health, will be using its first human participants today (Monday, March 16) to test the coronavirus vaccine for any potential side effects.
According to The Independent, those that have the vaccine will not have been infected with the virus beforehand.
Held at the Kaiser Permanente Washington Health Research Institute in Seattle, the trial will involve 45 healthy volunteers.
Even if the tests go well, experts have warned that it will most likely be a year until we have fully ready-to-use vaccine.
However, it isn’t just the US that is cracking down on discovering a vaccine for the potentially deadly COVID019. In the UK, researchers have announced that their vaccine could go through human trials as soon as June.
Researchers based at Imperial College London have said that the vaccine has proven to be successful on mice.
Dr Paul McKay told the Daily Express: “We’ve made a vaccine and already tested it in mice. I’ve got results from a month after I injected those, and the vaccine works really, really well.
“The next thing is that we need the government to fund us to do human clinical trials. The responses in the mice were huge so I really can’t see that it would be a poor response in people.”
Dr McKay then informed the newspaper team that they had applied for further funding to help get the vaccine is up and running, which is being led by Mucosal Infection and Immunity head Dr Robin Shattock.
“If we get the funding for the human clinical trials, we will put it into people by June,” he said.
“If British scientists here develop a vaccine it would be great if the government supported it.”
Similarly, the team have confirmed that it is likely to be at least a year before anything more will become available.